Skip to content

A Clinical Study of Connective Tissue Graft and Enamel Matrix Derivative in the Treatment of Intrabony Periodontal Defects

Efficacy of Connective Tissue Graft Wall Technique and Enamel Matrix Derivative in the Regenerative Treatment of Intrabony Periodontal Defects: A Prospective Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233733
Acronym
CTG + EMD
Enrollment
17
Registered
2025-11-18
Start date
2024-06-01
Completion date
2025-08-01
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases, Regeneration

Keywords

connective tissue, Enamel Matrix Derivative (EMD), Periodontal Regeneration, Infrabony Defects

Brief summary

This clinical study aims to evaluate the effectiveness of periodontal regenerative surgery using the connective tissue graft (CTG) wall technique combined with enamel matrix derivative (EMD) in patients who have intrabony periodontal defects. The purpose is to determine whether this combined approach can enhance both bone regeneration and soft-tissue stability compared with the patient's initial condition. Eligible participants will receive periodontal surgery in which a connective tissue graft and enamel matrix derivative are applied to the defect site. The study will monitor clinical improvements such as attachment gain, reduction in pocket depth, bone fill observed on cone-beam computed tomography (CBCT), and stability of the gingival margin and soft-tissue thickness. Clinical parameters (probing depth and attachment level) are recorded at baseline, 3 months, and 6 months. Gingival and hygiene parameters (recession, gingival thickness, plaque, and bleeding scores) are assessed at baseline, 1 month, 3 months, and 6 months. Radiographic bone outcomes are measured at baseline and 6 months, and early wound healing is assessed at 1 and 2 weeks. The main goal is to assess whether CTG + EMD treatment provides predictable periodontal regeneration, improved tissue stability, and better esthetic outcomes for patients with periodontitis.

Detailed description

This is a prospective, single-group interventional clinical trial conducted at the University of Medicine and Pharmacy at Ho Chi Minh City to evaluate the effectiveness of the connective tissue graft (CTG) wall technique combined with enamel matrix derivative (EMD, Emdogain®, Straumann) in the regenerative treatment of intrabony periodontal defects. The study included 17 patients diagnosed with stage III-IV periodontitis who presented with radiographically confirmed intrabony defects suitable for regenerative therapy. All participants received treatment following a standardized periodontal surgical protocol. After local anesthesia, a split-thickness vestibular releasing flap was prepared to allow coronal advancement, with external reflection of the papilla at the defect site. Thorough degranulation and root surface debridement were performed using ultrasonic and hand instruments. The root surface was conditioned with 24% EDTA gel for 2 minutes, rinsed with saline, and then enamel matrix derivative was applied onto the root surface and into the defect. A palatal connective tissue graft harvested using the four-incision technique was de-epithelialized, trimmed to span the papillae, and sutured to the buccal flap to form a stable soft-tissue wall. The flap was coronally advanced and secured with horizontal mattress and interrupted sutures to achieve tension-free primary closure. Clinical and radiographic outcomes are evaluated at multiple time points. Clinical parameters: probing pocket depth (PPD) and clinical attachment level (CAL) at baseline, 3 months, and 6 months. Soft-tissue and hygiene parameters: gingival recession (buccal and interproximal), gingival thickness, full-mouth plaque score (FMPS), and full-mouth bleeding score (FMBS) at baseline, 1, 3, and 6 months. Radiographic parameters: infrabony defect depth, buccal bone dehiscence, suprabony component, and defect angle measured on cone-beam computed tomography (CBCT) at baseline and 6 months. Early wound healing: assessed at 1 and 2 weeks using the Early Healing Index (EHI). The study was conducted at the Department of Periodontology, University of Medicine and Pharmacy at Ho Chi Minh City, between June 2024 and August 2025. The protocol was reviewed and approved by the Institutional Review Board of the University of Medicine and Pharmacy at Ho Chi Minh City (Approval No. 716/HĐĐĐ-ĐHYD, dated June 13, 2024). All participants provided written informed consent before enrollment.

Interventions

PROCEDUREConnective Tissue Graft (CTG) Wall Technique

After flap elevation and thorough degranulation/root debridement, a palatal connective tissue graft is harvested with the four-incision technique, de-epithelialized, and adapted to the buccal flap to create a stable soft-tissue wall.

PROCEDUREMinimally Invasive Flap Design

Split-thickness vestibular releasing flap with external papilla reflection to allow coronal advancement and preserve blood supply.

PROCEDURERoot Surface Preparation and Debridement

Thorough degranulation and root surface debridement using ultrasonic and hand instruments; intraoperative recording of defect depth and morphology.

BIOLOGICALGrowth Factor Application (EDTA + EMD)

Conditioning of the root surface with 24% EDTA gel for 2 minutes, rinsing, followed by application of enamel matrix derivative (EMD; Emdogain®) to the root surface and into the intrabony defect.

Combination of horizontal mattress and interrupted sutures to achieve tension-free primary closure.

875/125 mg orally, twice daily for 5 days, prescribed as postoperative antibiotic therapy.

400 mg orally, three times daily for 5 days, prescribed for postoperative pain and inflammation control.

0.12% solution, twice daily for 2 weeks, prescribed for chemical plaque control.

Sponsors

University of Medicine and Pharmacy at Ho Chi Minh City
CollaboratorOTHER
Phạm Đình Thiên Khải
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Outcome assessors were blinded to the surgical intervention. Examiners responsible for clinical and radiographic measurements were not involved in the surgical procedures and were unaware of the treatment allocation, ensuring unbiased data collection

Intervention model description

This is a single-arm interventional clinical trial in which all enrolled patients receive periodontal regenerative surgery using the connective tissue graft wall technique combined with enamel matrix derivative (Emdogain®). The model was selected to evaluate clinical and radiographic outcomes of this specific surgical approach without a comparator group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years old who can provide written informed consent. * Diagnosis of stage III-IV periodontitis (2017 World Workshop). * Completed initial non-surgical periodontal therapy with good plaque control. * Full-mouth plaque score (FMPS) ≤20% and full-mouth bleeding score (FMBS) ≤20%. * Presence of ≥1 intrabony periodontal defect with an intrabony component ≥3 mm, confirmed clinically and radiographically. * Probing pocket depth (PPD) at the study site ≥6 mm.

Exclusion criteria

* Systemic conditions or medications that could affect periodontal healing (e.g., diabetes mellitus, immunodeficiency, bisphosphonates, corticosteroids, immunosuppressants). * Current smokers or former heavy smokers. * Pregnancy or lactation. * Teeth with untreated endodontic lesions or non-vital status; furcation involvement class II-III. * Untreated occlusal trauma or tooth mobility grade II-III. * Third molars.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Attachment Level (CAL) GainBaseline 3 months, and 6 months post-surgeryChange in clinical attachment level measured at the treated intrabony periodontal defect, measured with UNC-15 probe and acrylic stent. The CAL is recorded as the distance from the cementoenamel junction (CEJ) to the base of the periodontal pocket. Unit: millimeters (mm). Negative change = gain (better).
Recession Interproximal (RECi)Baseline, one month, 3 months, 6 monthsDistance from the cusp tip or incisal edge to the interproximal gingival margin, measured in millimeters, to evaluate changes in papillary and proximal soft tissue level after treatment. Unit: millimeters (mm). Higher = worse.
Radiographic Intrabony Defect Fill (mm)Baseline and 6 months post-surgeryChange in vertical depth of the intrabony periodontal defect measured on CBCT at the treated site. Linear distance from the alveolar crest to the base of the defect along the root surface is recorded; greater positive values indicate more defect fill. Unit: millimeters (mm). Positive fill = better.
Recession Buccal (RECb)Baseline, 1 month, 3 months, and 6 months post-surgeryDistance from the cusp tip or incisal edge to the buccal gingival margin (zenith point), measured in millimeters, to evaluate changes in papillary and proximal soft tissue level after treatment. Unit: millimeters (mm). Higher = worse.
Probing Pocket Depth (PPD)Baseline, 3 months, and 6 monthsDistance from gingival margin to base of pocket with UNC-15 probe and stent. Negative change = reduction (better).

Secondary

MeasureTime frameDescription
Full-Mouth Bleeding Score (FMBS)Baseline, 1 month, 3 months, 6 monthsPercentage of tooth surfaces with bleeding after probing, assessed according to O'Leary et al. (1972). Unit: percentage (%). Lower = better.
Defect AngleBaseline and 6 months.Calculated as the angle formed between the root surface and bone crest at the defect site on CBCT images. Unit: degrees (°). Descriptive.
Buccal Bone DehiscenceBaseline, 6 months.Vertical distance from CEJ to the most apical part of buccal bone crest measured on CBCT to assess buccal bone resorption. Unit: millimeters (mm). Lower = better.
Suprabony ComponentBaseline, 6 monthsDistance from CEJ to alveolar bone crest measured on CBCT; indicates vertical bone loss height. Unit: millimeters (mm).
Tooth TypeAt baselineCategorical (Incisor / Canine / Premolar / Molar).
Sex/GenderAt baselineMale and Female
AgeAt baselineAdults, 18 years and older. Unit: years
Defect Depth at SurgeryAt surgeryDistance from bonecrest to base of defect measured intraoperatively in mm
Number of Remaining Bony WallsAt surgery and baselineNumber of residual bony walls at the intrabony defect, assessed intraoperatively. This classification follows the standard defect morphology description used by Tonetti et al. (1993, 1996). A lower number of walls indicates a less favorable prognosis, while a higher number indicates better regenerative potential.
Infrabony Defect DepthBaseline, 6 monthsDistance from the cemento-enamel junction (CEJ) to the base of the defect measured on CBCT; used to calculate defect depth. Unit: millimeters (mm). Descriptive
Defect LocationAt baselineCategorical (Maxilla / Mandible).
Gingival ThicknessBaseline, 3 months, 6 monthsBuccal gingival thickness measured mid-facially using probe transparency method as described by Kan et al. (2003). Unit: categorical (thin / thick). Thick = better.
Early Healing Index (EHI)1 week, 2 weeks post-surgeryEarly wound healing quality assessed according to Wachtel (2003) index. Unit: ordinal scale (1-5). 1 = best, 5 = worst.
Full-Mouth Plaque Score (FMPS)Baseline, 1 month, 3 months, 6 monthsPercentage of tooth surfaces with visible plaque after probing, assessed according to O'Leary et al. (1972). Unit: percentage (%). Lower = better.

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026